ID

33841

Description

Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Mots-clés

  1. 03/01/2019 03/01/2019 -
Détendeur de droits

GSK group of companies

Téléchargé le

3 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032

Liver Event Assessments

Administrative data
Description

Administrative data

Site
Description

Site

Type de données

text

Subject
Description

Subject

Type de données

text

Visit Name
Description

Visit Name

Type de données

text

Status
Description

Status

Type de données

text

Document Number
Description

Document Number

Type de données

text

Liver Events Assessment
Description

Liver Events Assessment

Have liver chemistry results reached or exceeded protocol-defined stopping criteria?
Description

If Yes, stop investigational product, complete date stopped on Investigational Product form, contact GSK within 24 hours of occurrence, complete Liver Events Form and obtain the following test: 1.Blood sample for PK analysis, obtained within three half-lives(21 days) of last dose; 2.Hepatitis A: IgM antibody; 3, Hepatitis B surface antigen and Core Antibody (IgM); 4. Hepatitis C: RNA; 5.Hepatitis E IgM antibody (if subject resides or has travelled in past 3 month outside the USA or Canada); 6. Cytomegalovirus IgM antibody (CMV); 7. EBV (Epstein Barr Viral capsid antigen IgM antibody)or if unavailable, obtain heterophile antibody or monospot testing; 8.CPK (Serum creatine phosphokinase); 9. LDH (lactate dehydrogenase); 10. Bilirubin fractionation, if bilirubin >=1.5xULN (If ALT >=3xULN and bilirubin >1.5xULN(>35% direct), the following are needed: anti-nuclear antibody, anti-smooth muscle antibody, tape 1 anti-liver kidney microsomal antibodies, liver imaging).

Type de données

boolean

Liver Events
Description

Liver Events

SAE / AE reference number
Description

SAE / AE reference number

Type de données

integer

Date of assessment
Description

Date of assessment

Type de données

date

Which liver chemistry result or exceeded protocol-defined investigational product stopping criteria?
Description

check all that apply

Type de données

text

If Other, specify
Description

If Other, specify

Type de données

text

Is the subject 55 or older?
Description

Is the subject 55 or older?

Type de données

boolean

If female, is the subject pregnant?
Description

if Yes, complete the Pregnancy Notification Form

Type de données

text

Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Description

Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?

Type de données

boolean

If Yes, were the results normal?
Description

if No, record the details on the Non-Serious Adverse Events form or Serious Adverse Events form.

Type de données

boolean

Were any liver biopsies performed?
Description

Were any liver biopsies performed?

Type de données

boolean

Does the subject use herbals, complementary or alternative medicines?
Description

If Yes, record on the appropriate Concomitant Medication form

Type de données

boolean

Did the subject fast or undergo significant dietary change in the past week?
Description

Did the subject fast or undergo significant dietary change in the past week?

Type de données

boolean

Was a pharmacokinetic blood sample obtained?
Description

An unscheduled PK blood sample must be obtained within three half-lives (21 days) of last dose.

Type de données

boolean

Date of sample taken
Description

Date of sample taken

Type de données

date

Time of sample taken
Description

Time of sample taken

Type de données

time

Record date and time of last investigational product dose prior to PK sample (if administered at subject's home, please do not record the time)
Description

Record date and time of last investigational product dose prior to PK sample (if administered at subject's home, please do not record the time)

Type de données

datetime

Alcohol Intake
Description

Alcohol Intake

The average number of units of alcohol consumed per week:
Description

The average number of units of alcohol consumed per week:

Type de données

integer

Unités de mesure
  • units per week
units per week
Liver Disease Medical Conditions
Description

Liver Disease Medical Conditions

1. Acute viral Hepatitis A
Description

1. Acute viral Hepatitis A

Type de données

text

2. Chronic Hepatitis B
Description

2. Chronic Hepatitis B

Type de données

text

3. Chronic Hepatitis C
Description

3. Chronic Hepatitis C

Type de données

text

4. Cytomegalovirus Hepatitis
Description

4. Cytomegalovirus Hepatitis

Type de données

text

5. Epstein Barr virus infectious mononucleosis
Description

5. Epstein Barr virus infectious mononucleosis

Type de données

text

6. Herpes Simplex Hepatitis
Description

6. Herpes Simplex Hepatitis

Type de données

text

7. Alcoholic liver disease
Description

7. Alcoholic liver disease

Type de données

text

8. Non-alcoholic steatohepatitis
Description

8. Non-alcoholic steatohepatitis

Type de données

text

9. Fatty Liver
Description

9. Fatty Liver

Type de données

text

10. Hepatic Cirrhosis
Description

10. Hepatic Cirrhosis

Type de données

text

11. Hemochromatosis
Description

11. Hemochromatosis

Type de données

text

12. Autoimmune Hepatitis
Description

12. Autoimmune Hepatitis

Type de données

text

13. Gallbladder disease or biliary disease
Description

13. Gallbladder disease or biliary disease

Type de données

text

Drug Related Liver Disease Conditions
Description

Drug Related Liver Disease Conditions

14. Specific condition:
Description

specify here

Type de données

text

Status of condition
Description

Status of condition

Type de données

text

15. Specific condition
Description

15. Specific condition

Type de données

text

Status of condition
Description

Status of condition

Type de données

text

15. Specific condition
Description

15. Specific condition

Type de données

text

Status of condition
Description

Status of condition

Type de données

text

Other Medical Conditions
Description

Other Medical Conditions

17. Drug allergies
Description

17. Drug allergies

Type de données

text

18. Rheumatoid Arthritis
Description

18. Rheumatoid Arthritis

Type de données

text

19. Psoriasis
Description

19. Psoriasis

Type de données

text

20. Thyroid disease
Description

20. Thyroid disease

Type de données

text

21. Inflammatory bowel disease
Description

21. Inflammatory bowel disease

Type de données

text

22. Lupus
Description

22. Lupus

Type de données

text

23. Sjoren's syndrome
Description

23. Sjoren's syndrome

Type de données

text

24. Vitiligo
Description

24. Vitiligo

Type de données

text

Similar models

Liver Event Assessments

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
Site
Item
Site
text
Subject
Item
Subject
text
Item
Visit Name
text
Code List
Visit Name
CL Item
Liver Event Assessment (1)
Status
Item
Status
text
Document Number
Item
Document Number
text
Item Group
Liver Events Assessment
Have liver chemistry results reached or exceeded protocol-defined stopping criteria?
Item
Have liver chemistry results reached or exceeded protocol-defined stopping criteria?
boolean
Item Group
Liver Events
SAE / AE reference number
Item
SAE / AE reference number
integer
Date of assessment
Item
Date of assessment
date
Item
Which liver chemistry result or exceeded protocol-defined investigational product stopping criteria?
text
Code List
Which liver chemistry result or exceeded protocol-defined investigational product stopping criteria?
CL Item
ALT (alanine aminotransferase) (1)
CL Item
AST (aspartate aminotransferase) (2)
CL Item
Total bilirubin (3)
CL Item
Other (4)
If Other, specify
Item
If Other, specify
text
Is the subject 55 or older?
Item
Is the subject 55 or older?
boolean
Item
If female, is the subject pregnant?
text
Code List
If female, is the subject pregnant?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not Applicable (3)
Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Item
Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as a liver ultrasound, computerized tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
boolean
If Yes, were the results normal?
Item
If Yes, were the results normal?
boolean
Were any liver biopsies performed?
Item
Were any liver biopsies performed?
boolean
Does the subject use herbals, complementary or alternative medicines?
Item
Does the subject use herbals, complementary or alternative medicines?
boolean
Did the subject fast or undergo significant dietary change in the past week?
Item
Did the subject fast or undergo significant dietary change in the past week?
boolean
Was a pharmacokinetic blood sample obtained?
Item
Was a pharmacokinetic blood sample obtained?
boolean
Date of sample taken
Item
Date of sample taken
date
Time of sample taken
Item
Time of sample taken
time
Record date and time of last investigational product dose prior to PK sample (if administered at subject's home, please do not record the time)
Item
Record date and time of last investigational product dose prior to PK sample (if administered at subject's home, please do not record the time)
datetime
Item Group
Alcohol Intake
The average number of units of alcohol consumed per week:
Item
The average number of units of alcohol consumed per week:
integer
Item Group
Liver Disease Medical Conditions
Item
1. Acute viral Hepatitis A
text
Code List
1. Acute viral Hepatitis A
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
2. Chronic Hepatitis B
text
Code List
2. Chronic Hepatitis B
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
3. Chronic Hepatitis C
text
Code List
3. Chronic Hepatitis C
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
4. Cytomegalovirus Hepatitis
text
Code List
4. Cytomegalovirus Hepatitis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
5. Epstein Barr virus infectious mononucleosis
text
Code List
5. Epstein Barr virus infectious mononucleosis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
6. Herpes Simplex Hepatitis
text
Code List
6. Herpes Simplex Hepatitis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
7. Alcoholic liver disease
text
Code List
7. Alcoholic liver disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
8. Non-alcoholic steatohepatitis
text
Code List
8. Non-alcoholic steatohepatitis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
9. Fatty Liver
text
Code List
9. Fatty Liver
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
10. Hepatic Cirrhosis
text
Code List
10. Hepatic Cirrhosis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
11. Hemochromatosis
text
Code List
11. Hemochromatosis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
12. Autoimmune Hepatitis
text
Code List
12. Autoimmune Hepatitis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
13. Gallbladder disease or biliary disease
text
Code List
13. Gallbladder disease or biliary disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item Group
Drug Related Liver Disease Conditions
14. Specific condition:
Item
14. Specific condition:
text
Item
Status of condition
text
Code List
Status of condition
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
15. Specific condition
Item
15. Specific condition
text
Item
Status of condition
text
Code List
Status of condition
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
15. Specific condition
Item
15. Specific condition
text
Item
Status of condition
text
Code List
Status of condition
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item Group
Other Medical Conditions
Item
17. Drug allergies
text
Code List
17. Drug allergies
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
18. Rheumatoid Arthritis
text
Code List
18. Rheumatoid Arthritis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
19. Psoriasis
text
Code List
19. Psoriasis
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
20. Thyroid disease
text
Code List
20. Thyroid disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
21. Inflammatory bowel disease
text
Code List
21. Inflammatory bowel disease
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
22. Lupus
text
Code List
22. Lupus
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
23. Sjoren's syndrome
text
Code List
23. Sjoren's syndrome
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)
Item
24. Vitiligo
text
Code List
24. Vitiligo
CL Item
Current (1)
CL Item
Past (2)
CL Item
No medical conditions (3)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial